logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Adrenocortical Insufficiency Chronic

    FiltersReset Filters
    25 results

    • alkindi

      (Hydrocortisone)
      Eton Pharmaceuticals, Inc.
      Usage: ALKINDI SPRINKLE is indicated for replacement therapy in pediatric patients suffering from adrenocortical insufficiency.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for severe allergic states, dermatoses, endocrine and gastrointestinal disorders, hematologic conditions, certain neoplasms, and respiratory diseases. It also treats nervous system issues, renal problems, and rheumatic diseases. Additionally, it can be administered intra-articularly for arthritis and intralesionally for specific dermatologic conditions.

    • depo-medrol

      (methylprednisolone acetate)
      Pharmacia & Upjohn Company LLC
      Usage: DEPO-MEDROL is indicated for various conditions, including severe allergic reactions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic issues, and certain rheumatic diseases. It is also used for cerebral edema, palliative care in neoplastic diseases, and localized therapies in dermatologic conditions via intralesional or intra-articular administration.

    • fludrocortisone acetate

      (FLUDROCORTISONE ACETATE)
      AvKARE
      Usage: Fludrocortisone acetate tablets, 0.1 mg, are indicated for partial replacement therapy in primary and secondary adrenocortical insufficiency, including Addison’s disease, and for treating salt-losing adrenogenital syndrome.

    • fludrocortisone acetate

      (FLUDROCORTISONE ACETATE)
      Amneal Pharmaceuticals of New York LLC
      Usage: Fludrocortisone acetate tablets, 0.1 mg are indicated for partial replacement therapy in primary and secondary adrenocortical insufficiency (Addison’s disease) and for treating salt-losing adrenogenital syndrome.

    • hydrocortisone

      (Hydrocortisone)
      Chartwell RX, LLC
      Usage: Hydrocortisone Tablets are indicated for treating endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, severe allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and specific miscellaneous conditions such as tuberculous meningitis and trichinosis.

    • hydrocortisone

      (Hydrocortisone)
      Chartwell RX, LLC.
      Usage: Hydrocortisone tablets are indicated for various conditions, including endocrine disorders (adrenocortical insufficiency, congenital adrenal hyperplasia), rheumatic disorders, allergic states, dermatologic diseases, respiratory issues, hematologic disorders, neoplastic diseases, gastrointestinal diseases, and specific infectious processes, often as adjunctive or palliative therapy.

    • khindivi

      (Hydrocortisone)
      Eton Pharmaceuticals, Inc.
      Usage: KHINDIVI is indicated for replacement therapy in pediatric patients aged 5 and older with adrenocortical insufficiency. It is not approved for increased dosing during stress or acute events; alternative hydrocortisone-containing products should be used for those situations.

    • methylprednisolone

      (methylprednisolone)
      Zydus Pharmaceuticals USA Inc.
      Usage: Methylprednisolone tablets are indicated for various conditions, including endocrine disorders, rheumatic diseases, collagen diseases, dermatologic and allergic conditions, ophthalmic diseases, respiratory issues, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, and acute exacerbations of multiple sclerosis. It serves as adjunctive therapy or management in these cases.

    • methylprednisolone

      (Methylprednisolone)
      Amneal Pharmaceuticals LLC
      Usage: Methylprednisolone tablets are indicated for treating endocrine disorders, rheumatic diseases, allergic states, ocular and respiratory diseases, hematologic disorders, neoplastic diseases, gastrointestinal conditions, nervous system exacerbations, and certain dermatologic conditions. It provides relief in severe cases where conventional treatments are inadequate.